Big Grants Boost New Ways to Save Babies and Fight Overdoses
Revolutionizing Prenatal Care with a Rapid Blood Test
The University of California, San Diego has just landed two major research grants totaling $16 million, pushing the boundaries of medical innovation. The first, from the Advanced Research Projects Agency for Health (ARPA-H), funds a life-saving blood test for expectant mothers.
Led by electrical engineering professor Drew Hall and OB/GYN researcher Louise Laurent, the team aims to detect early signs of oxygen deprivation in newborns by analyzing microscopic DNA fragments and proteins in the mother’s blood. If successful, this could allow doctors to intervene sooner, drastically improving infant outcomes.
AI "Digital Twins" to Transform HIV, Hepatitis C, and Overdose Treatment
The second grant—a $5.6 million Avant-Garde Award from the National Institute on Drug Abuse—backs a project led by mathematical biologist Natasha Martin. Her team is developing artificial intelligence "digital twins"—virtual models that simulate how individuals with HIV, hepatitis C, or opioid addiction respond to treatments and prevention strategies.
By testing interventions in a virtual environment first, researchers hope to:
- Optimize care strategies before real-world application
- Uncover hidden barriers to treatment access
- Design more effective health services for at-risk populations
A New Era of Precision Medicine
These projects highlight a global shift toward predictive, personalized healthcare—where technology helps anticipate health risks before they escalate. The funding also aligns with a national push to integrate advanced science into everyday medical practice, particularly in critical care scenarios where early action saves lives.
With these grants, UC San Diego is not just advancing research—it’s reshaping the future of medicine.
